Summary:
Umbilical cord blood (CB) has been rapidly established as an alternative source of stem cells to bone marrow for allogeneic-related and unrelated hematopoietic transplantation. To date, almost 70 000 CB units are available for transplantation and more than 2000 CB transplants (CBT) have been performed, mostly in children, for the treatment of a variety of malignant and nonmalignant conditions. Considerable experience has been rapidly accumulated in this field and many aspects of CBT have been elucidated, while other questions remain unresolved. A concise review of the clinical results achieved after related and unrelated CBT is presented and discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119–10122.
Knudtzon S . In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 1974; 43: 357–361.
Nakahata T, Ogawa M . Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J Clin Invest 1982; 70: 1324–1328.
Emerson SG, Sieff CA, Wang EA et al. Purification of fetal hematopoietic progenitors and demonstration of recombinant. J Clin Invest 1985; 76: 1286–1290.
Christensen RD, Harper TE, Rothstein G . Granulocyte-macrophage progenitor cells in term and preterm neonates. J Pediatr 1986; 109: 1047–1051.
Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828–3832.
Gluckman E, Broxmeyer HA, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–1178.
Broxmeyer HE, Hangoc G, Cooper S et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992; 89: 4109–4113.
Cardoso AA, Li ML, Batard P et al. Human umbilical cord blood CD34+ cell purification with high yield of early progenitors. J Hematother 1993; 2: 275–279.
Lu L, Xiao M, Shen RN et al. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 1993; 81: 41–48.
Han P, Hodge G, Story C et al. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br J Haematol 1995; 89: 733–740.
Risdon G, Gaddy J, Horie M et al. Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci USA 1995; 92: 2413–2417.
Barker JN, Krepski TP, DeFor TE et al. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood vs bone marrow. Biol Blood and Bone Marrow Transplant 2002; 8: 257–260.
Rubinstein P, Rosenfield RE, Adamson JW et al. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993; 81: 1679–1690.
McCullough J, Clay ME, Fautsch S et al. Proposed policies and procedures for the establishment of a cord blood bank. Blood Cells 1994; 20: 609–626.
Donaldson C, Armitage WJ, Denning-Kendall PA et al. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant 1996; 18: 725–731.
Wagner JE, Broxmeyer HE, Cooper S . Umbilical cord and placental blood hematopoietic stem cells: collection, cryopreservation, and storage. J Hematother 1992; 1: 167–173.
Harris DT, Schumacher MJ, Rychlik S et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant 1994; 13: 135–143.
Cairo M, Wagner JE . Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90: 4665–4678.
Reed W, Smith R, Dekovic F et al. Comprehensive banking of sibling donor cord blood for children with malignant and non-malignant disease. Blood 2003; 101: 351–357.
International Forum. Use of umbilical cord blood progenitor cells as an alternative therapy for bone marrow transplantation. Vox Sanguinis 2002; 83: 172–187.
Wagner JE, Kernan NA, Steinbuch M et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214–219.
Wagner JE, Kurtzberg J . Cord blood stem cells. Curr Opin Hematol 1997; 4: 413–418.
Rocha V, Chastang C, Souillet G et al. Related cord blood transplants: the Eurocord experience from 78 transplants. Eurocord Transplant Group. Bone Marrow Transplant 1998; 21 (Suppl. 3): S59–S62.
Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373–381.
Gluckman E . Current status of umbilical cord blood hematopoietic stem cells transplantation. Exp Hematol 2000; 28: 1197–1205.
Rocha V, Wagner Jr JE, Sobocinski KA et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846–1854.
Gluckman E, Rocha V, Chastang C . European results of unrelated cord blood transplants. Eurocord Group. Bone Marrow Transplant 1998; 21 (Suppl. 3): S87–S91.
Gluckman E, Rocha V, Garnier F et al. Analysis of factors associated with engraftment after umbilical cord blood transplantation. Blood 2001; 96: 588a.
Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577.
Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157–166.
Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-vs-host disease. Blood 1996; 88: 795–802.
Thomson BG, Robertson KA, Gowan D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703–2711.
Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.
Barker JN, Davies SM, DeFor T et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–2961.
Locatelli F, Rocha V, Chastang C et al. Cord blood transplantation for children with acute leukemia. Eurocord Transplant Group. Bone Marrow Transplant 1998; 21 (Suppl. 3): S63–S65.
Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999; 93: 3662–3671.
Michel G, Rocha V, Arcese W et al. Unrelated cord blood transplantation for childhood AML. Blood 2002; 100 (Suppl. 1): 41a.
Rocha V, Cornish J, Sievers EL et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2971.
Gluckman E, Rocha V, Chevret S et al. Factors associated with outcome if unrelated cord blood transplant: guidelines for donor choice. An Eurocord study. Blood 2002; 100 (Suppl. 1): 642a.
Rubinstein P, Kurtzberg J, Loberiza F et al. Comparison of unrelated cord blood and unrelated bone marrow transplants for leukemia in children: a collaborative study of the New York Blood Center and the International Bone Marrow Transplant Registry. Blood 1998; 92 (Suppl. 1): 814a.
Locatelli F, Rocha V, Reed W et al. Related umbilical cord blood transplant in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137–2143.
Rocha V, Chastang C, Pasquini R et al. Cord blood transplant in patients with bone marrow failure syndromes. Blood 1998; 92 (Suppl. 1): 136a.
Howrey RP, Martin PL, Ciocci G et al. Unrelated cord blood transplantation for correction of genetic diseases. Blood 1998; 92 (Suppl. 1): 291a.
Niehues T, Rocha V, Filipovich AH et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children: a Eurocord analysis. Br J Haematol 2001; 114: 42–48.
Ortega J, Yaniv L, Rocha V et al. Cord blood transplantation for inborn errors. Blood 1998; 92 (Suppl. 1): 291a.
Ortega JJ, Rocha V, Wall D et al. Unrelated cord blood transplant in children with severe primary immunodeficiencies. An Eurocord analysis. Blood 2001; 98 (Suppl. 1): 667a.
Staba SL, Martin PL, Ciocci GH et al. Correction of Hurler syndrome with unrelated umbilical cord blood transplantation. Blood 2001; 98 (Suppl. 1): 667a.
Gluckman E . Hematopoietic stem cell transplants using umbilical cord blood. N Engl J Med 2001; 344: 1860–1861.
Rocha V, Sanz G, Laporte JP et al. Prognostic factors of outcome after unrelated cord blood transplant in adults with hematologic malignancies. Blood 2000; 96 (Suppl. 1): 587a.
Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.
Iseki T, Ooi J, Tomonari A et al. Unrelated cord blood transplantation in adult patients with hematological malignancy. A single institution experience. Blood 2001; 98 (Suppl. 1): 665a.
Sanz GF, Saavedra S, Planelles D et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001; 98: 2332–2338.
Long G, Madan B, Kurtzberg J et al. Unrelated umbilical cord blood transplants in adult patients with hematologic malignancies and genetic disorders. Blood 1999; 94 (Suppl. 1): 570a.
Rocha V, Labopin M, Frassoni F et al. Results of unrelated cord blood versus unrelated bone marrow transplant in adults with acute leukemia. A matched pair analysis. Blood 2002; 100 (Suppl. 1): 42a.
Ooi J, Iseki T, Takahashi S et al. A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukemia. Br J Haematol 2002; 118: 140–143.
Abu-Ghosh A, Goldman S, Slone V et al. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation. Bone Marrow Transplant 1999; 24: 535–544.
Moretta A, Maccario R, Fagioli F et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29: 371–379.
Talvensaari K, Clave E, Donay C et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002; 99: 1458–1464.
Stevens CE, Gladstone J, Taylor PE et al. Placental/umbilical cord blood from unrelated donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood 2002; 100: 2662–2664.
Migliaccio AR, Adamson JW, Stevens CE et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717–2722.
Kogler G, Nurnberger W, Fischer J et al. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high-risk leukemia. Bone Marrow Transplant 1999; 24: 397–403.
Pecora AL, Stiff P, Jennis A et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000; 25: 797–799.
Kohn DB, Weinberg KI, Nolta JA et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995; 1: 1017–1023.
Shpall EJ, Quinones R, Giller R et al. Transplantation of ex vivo expanded cord blood. Biol Blood and Bone Marrow Transplant 2002; 8: 368–376.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benito, A., Diaz, M., González-Vicent, M. et al. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 33, 675–690 (2004). https://doi.org/10.1038/sj.bmt.1704405
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704405
Keywords
This article is cited by
-
Isolation and quantification of DNA from epithelial cells obtained from acrylic removable partial denture for sex identification
Egyptian Journal of Forensic Sciences (2019)
-
Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor
BMC Biotechnology (2017)
-
Hetrombopag, a Thrombopoietin Receptor Agonist, Protects Cardiomyocyte Survival from Oxidative Stress Damage as an Enhancer of Stem Cells
Cardiovascular Drugs and Therapy (2016)
-
G-CSF-primed BM for allogeneic SCT: revisited
Bone Marrow Transplantation (2015)
-
Unrelated Umbilical Cord Blood Transplant for Children with β-Thalassemia Major
Indian Journal of Hematology and Blood Transfusion (2015)